Thomas Eastling - 16 Apr 2025 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Director
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Thomas Eastling
Issuer symbol
GYRE
Transactions as of
16 Apr 2025
Net transactions value
+$103,950
Form type
4
Filing time
18 Apr 2025, 17:27:15 UTC
Previous filing
16 Aug 2024
Next filing
06 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GYRE Common Stock Options Exercise $103,950 +15,000 $6.93 15,000 16 Apr 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Options Exercise $0 -15,000 -4.8% $0.000000 299,652 16 Apr 2025 Common Stock 15,000 $6.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are vested in full.